{Reference Type}: Journal Article
{Title}: Human Organoids for Rapid Validation of Gene Variants Linked to Cochlear Malformations.
{Author}: Zafeer MF;Ramzan M;Duman D;Mutlu A;Seyhan S;Kalcioglu T;Fitoz S;DeRosa BA;Guo S;Dykxhoorn DM;Tekin M;
{Journal}: Res Sq
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 11
暂无{DOI}: 10.21203/rs.3.rs-4474071/v1
{Abstract}: Developmental anomalies of the hearing organ, the cochlea, are diagnosed in approximately one-fourth of individuals with congenital deafness. Most patients with cochlear malformations remain etiologically undiagnosed due to insufficient knowledge about underlying genes or the inability to make conclusive interpretations of identified genetic variants. We used exome sequencing for genetic evaluation of hearing loss associated with cochlear malformations in three probands from unrelated families. We subsequently generated monoclonal induced pluripotent stem cell (iPSC) lines, bearing patient-specific knockins and knockouts using CRISPR/Cas9 to assess pathogenicity of candidate variants. We detected FGF3 (p.Arg165Gly) and GREB1L (p.Cys186Arg), variants of uncertain significance in two recognized genes for deafness, and PBXIP1(p.Trp574*) in a candidate gene. Upon differentiation of iPSCs towards inner ear organoids, we observed significant developmental aberrations in knockout lines compared to their isogenic controls. Patient-specific single nucleotide variants (SNVs) showed similar abnormalities as the knockout lines, functionally supporting their causality in the observed phenotype. Therefore, we present human inner ear organoids as a tool to rapidly validate the pathogenicity of DNA variants associated with cochlear malformations.